← Back to Analyst Consensus 
BIVI Buy
BIOVIE INC.
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 9, 2026 (14 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jul 1, 2024 | ThinkEquity | initiate | — → Buy | $3 | — |
| Nov 30, 2023 | Oppenheimer | maintain | Outperform → Outperform | $5 | 52% |
| Aug 22, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $11 | 50% |
| Jul 18, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $11 | 50% |
| May 17, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $11 | 50% |
| May 17, 2023 | Oppenheimer | reiterate | Outperform → Outperform | $12 | 52% |
| Feb 14, 2023 | Oppenheimer | reiterate | — → Outperform | $12 | 52% |
| Sep 28, 2022 | EF Hutton | maintain | — → Buy | $8 | 30% |
| Jul 22, 2022 | Cantor Fitzgerald | initiate | — → Overweight | $7 | 50% |
| Mar 17, 2022 | EF Hutton | maintain | — → Buy | $14 | 30% |
| Mar 15, 2022 | Oppenheimer | initiate | — → Outperform | $9 | 52% |
| Nov 30, 2021 | B. Riley Securities | maintain | — → Buy | $27 | 55% |
| Jan 15, 2021 | B. Riley FBR | initiate | — → Buy | $47 | — |
Price Target Trend
Jun 7, 2026 Latest: $5.26 Oct 25, 2026
EPS Estimates
+1q —
0y $-0.63
Lo: $-0.63 Hi: $-0.63
1 analysts 0q —
+1y $-0.57
Lo: $-0.57 Hi: $-0.57
1 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days